Literature DB >> 17233122

Rapid emergence of methicillin-resistant Staphylococcus aureus (MRSA) among children and adolescents in northern Manitoba, 2003-2006.

L Larcombe1, J Waruk, J Schellenberg, M Ormond.   

Abstract

Entities:  

Mesh:

Year:  2007        PMID: 17233122

Source DB:  PubMed          Journal:  Can Commun Dis Rep        ISSN: 1188-4169


× No keyword cloud information.
  5 in total

Review 1.  Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic.

Authors:  Michael Z David; Robert S Daum
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

2.  Community-based educational intervention to limit the dissemination of community-associated methicillin-resistant Staphylococcus aureus in Northern Saskatchewan, Canada.

Authors:  George R Golding; Brian Quinn; Kirsten Bergstrom; Donna Stockdale; Shirley Woods; Mandiangu Nsungu; Barb Brooke; Paul N Levett; Greg Horsman; Ryan McDonald; Brian Szklarczuk; Steve Silcox; Shirley Paton; Mary Carson; Michael R Mulvey; James Irvine
Journal:  BMC Public Health       Date:  2012-01-06       Impact factor: 3.295

3.  High rates of Staphylococcus aureus USA400 infection, Northern Canada.

Authors:  George R Golding; Paul N Levett; Ryan R McDonald; James Irvine; Brian Quinn; Mandiangu Nsungu; Shirley Woods; Mohammad Khan; Marianna Ofner-Agostini; Michael R Mulvey
Journal:  Emerg Infect Dis       Date:  2011-04       Impact factor: 6.883

Review 4.  Community-associated MRSA among Indigenous children in remote settings: Best practices for NPs.

Authors:  Rhonda Campbell; Donna Martin; Darlene Pierce; Sochimaobi Nweze
Journal:  Nurse Pract       Date:  2020-10

5.  A cross sectional study of animal and human colonization with Methicillin-Resistant Staphylococcus aureus (MRSA) in an Aboriginal community.

Authors:  Peter Daley; Janak Bajgai; Carla Penney; Karen Williams; Hugh Whitney; George R Golding; Scott Weese
Journal:  BMC Public Health       Date:  2016-07-19       Impact factor: 3.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.